488 related articles for article (PubMed ID: 29775725)
1. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Anti-HCV Activity of Multiple Punica granatum Extracts and Fractions in Virus-infected Human Hepatocytes.
Rehman S; Ashfaq UA; Ijaz B; Jabeen Z; Riazuddin S
Curr Pharm Biotechnol; 2018; 19(15):1221-1231. PubMed ID: 30608038
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
[TBL] [Abstract][Full Text] [Related]
4. Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease.
Noreen S; Hussain I; Tariq MI; Ijaz B; Iqbal S; Qamar-ul-Zaman ; Ashfaq UA; Husnain T
Viral Immunol; 2015 Jun; 28(5):282-9. PubMed ID: 25871297
[TBL] [Abstract][Full Text] [Related]
5. Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba.
Manvar D; Mishra M; Kumar S; Pandey VN
J Ethnopharmacol; 2012 Dec; 144(3):545-54. PubMed ID: 23026306
[TBL] [Abstract][Full Text] [Related]
6. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
7. A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage.
Reddy BU; Mullick R; Kumar A; Sharma G; Bag P; Roy CL; Sudha G; Tandon H; Dave P; Shukla A; Srinivasan P; Nandhitha M; Srinivasan N; Das S
Antiviral Res; 2018 Feb; 150():47-59. PubMed ID: 29224736
[TBL] [Abstract][Full Text] [Related]
8. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
[TBL] [Abstract][Full Text] [Related]
9. Anti-Hepatitis C Virus Activity of a Crude Extract from Longan (Dimocarpus longan Lour.) Leaves.
Apriyanto DR; Aoki C; Hartati S; Hanafi M; Kardono LB; Arsianti A; Louisa M; Sudiro TM; Dewi BE; Sudarmono P; Soebandrio A; Hotta H
Jpn J Infect Dis; 2016 May; 69(3):213-20. PubMed ID: 26255732
[TBL] [Abstract][Full Text] [Related]
10. Anti-hepatitis C virus and synergistic potential of Syzgium cumine a bioassay guided screening in liver-infected hepatocytes.
Riaz S; Tiwana H; Adil M; Ali K; Javed T
Arch Microbiol; 2021 Dec; 204(1):69. PubMed ID: 34951685
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor.
Wahyuni TS; Mahfud H; Permatasari AA; Widyawaruyanti A; Fuad A
J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837259
[TBL] [Abstract][Full Text] [Related]
12. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
[TBL] [Abstract][Full Text] [Related]
13. Antiviral phytochemicals identification from Azadirachta indica leaves against HCV NS3 protease: an in silico approach.
Ashfaq UA; Jalil A; Ul Qamar MT
Nat Prod Res; 2016 Aug; 30(16):1866-9. PubMed ID: 26274064
[TBL] [Abstract][Full Text] [Related]
14. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
15. Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease.
Khan M; Rauf W; Habib FE; Rahman M; Iqbal S; Shehzad A; Iqbal M
BMC Complement Med Ther; 2022 Apr; 22(1):98. PubMed ID: 35366855
[TBL] [Abstract][Full Text] [Related]
16. VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells.
Lin K; Perni RB; Kwong AD; Lin C
Antimicrob Agents Chemother; 2006 May; 50(5):1813-22. PubMed ID: 16641454
[TBL] [Abstract][Full Text] [Related]
17. Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection.
Chen SH; Tan SL
Curr Med Chem; 2005; 12(20):2317-42. PubMed ID: 16181135
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.
Ravikumar YS; Ray U; Nandhitha M; Perween A; Raja Naika H; Khanna N; Das S
Virus Res; 2011 Jun; 158(1-2):89-97. PubMed ID: 21440018
[TBL] [Abstract][Full Text] [Related]
19. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
